このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Coral Laboratories マネジメント

マネジメント基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Girish Dhameja

最高経営責任者

₹2.8m

報酬総額

CEO給与比率	98.0%
CEO在任期間	7.4yrs
CEOの所有権	n/a
経営陣の平均在職期間	データなし
取締役会の平均在任期間	5.4yrs

経営陣の近況

Recent updates

CEO報酬分析

Coral Laboratories の収益と比較して、Girish Dhameja の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Jun 30 2024	n/a	n/a	₹228m
Mar 31 2024	₹3m	₹3m	₹158m
Dec 31 2023	n/a	n/a	₹91m
Sep 30 2023	n/a	n/a	₹78m
Jun 30 2023	n/a	n/a	₹67m
Mar 31 2023	₹3m	₹3m	₹64m
Dec 31 2022	n/a	n/a	₹99m
Sep 30 2022	n/a	n/a	₹93m
Jun 30 2022	n/a	n/a	₹48m
Mar 31 2022	₹3m	₹3m	₹90m
Dec 31 2021	n/a	n/a	₹82m
Sep 30 2021	n/a	n/a	₹126m
Jun 30 2021	n/a	n/a	₹141m
Mar 31 2021	₹3m	₹3m	₹136m
Dec 31 2020	n/a	n/a	₹153m
Sep 30 2020	n/a	n/a	₹129m
Jun 30 2020	n/a	n/a	₹120m
Mar 31 2020	₹2m	₹2m	₹71m
Dec 31 2019	n/a	n/a	₹25m
Sep 30 2019	n/a	n/a	₹33m
Jun 30 2019	n/a	n/a	₹70m
Mar 31 2019	₹2m	₹2m	₹102m
Dec 31 2018	n/a	n/a	₹144m
Sep 30 2018	n/a	n/a	₹134m
Jun 30 2018	n/a	n/a	₹141m
Mar 31 2018	₹2m	₹2m	₹124m

報酬と市場: Girishの総報酬 ($USD 33.68K ) は、 Indian市場 ($USD 39.08K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Girishの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Girish Dhameja (43 yo)

7.4yrs

在職期間

₹2,813,435

報酬

Mr. Girish Madanlal Dhameja has been an Whole-Time Director of Coral Laboratories Limited since May 26, 2017. His present profile includes handling export enquiry finalization and execution of order, busin...

取締役

名称	ポジション	在職期間	報酬	所有権
Girish Dhameja	Whole-Time Director	7.4yrs	₹2.81m	データなし
Sushma Kadkade	CFO & Non-Executive Director	7.4yrs	₹1.26m	データなし
Sheela Kamdar	Non-Executive Independent Director	10.2yrs	₹43.00k	データなし
Saurabh Shah	Independent Director	5.4yrs	₹15.00k	データなし
Malay Doshi	Independent Director	3.4yrs	データなし	データなし
Rajendrasinh Rana	Non-Executive Director	3.1yrs	データなし	データなし
Pooja Hindia	Independent Director	less than a year	データなし	データなし

5.4yrs

平均在職期間

43yo

平均年齢

経験豊富なボード: 524506の取締役会は経験豊富であると考えられます ( 6.1年の平均在任期間)。

Coral Laboratories マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

Insufficient new directors

Coral Laboratories Limited, Annual General Meeting, Sep 27, 2024

Coral Laboratories Limited Announces Cessation of Sheela Kamdar as Independent Director

Coral Laboratories Limited Announces Resignation of Ruchi Pipara as Company Secretary and Compliance Officer, with Effect from July 13, 2024

Coral Laboratories Limited Appoints Ruchi Pipara as Company Secretary, Compliance Officer and Key Managerial Personnel

Coral Laboratories Limited Announces Resignation of Shifa Memon as Company Secretary, Compliance Officer and Key Managerial Personnel

Recent updates

Insufficient new directors

Upcoming dividend of ₹2.00 per share

Investor sentiment improves as stock rises 22%

New major risk - Share price stability

Coral Laboratories Limited, Annual General Meeting, Sep 27, 2024

First quarter 2025 earnings released: EPS: ₹24.64 (vs ₹5.16 in 1Q 2024)

Coral Laboratories Limited Announces Cessation of Sheela Kamdar as Independent Director

Coral Laboratories Limited to Report Q1, 2025 Results on Aug 14, 2024

Coral Laboratories Limited Announces Resignation of Ruchi Pipara as Company Secretary and Compliance Officer, with Effect from July 13, 2024

Investor sentiment improves as stock rises 19%

New minor risk - Share price stability

Investor sentiment improves as stock rises 20%

Coral Laboratories Limited to Report Q4, 2024 Results on May 23, 2024

Coral Laboratories Limited Appoints Ruchi Pipara as Company Secretary, Compliance Officer and Key Managerial Personnel

Coral Laboratories Limited Announces Resignation of Shifa Memon as Company Secretary, Compliance Officer and Key Managerial Personnel

Coral Laboratories Limited Appoints Shifa Memon as Company Secretary and Compliance Officer, with Effect from March 9, 2024

Investor sentiment improves as stock rises 16%

Now 20% overvalued

Third quarter 2024 earnings released: EPS: ₹6.04 (vs ₹2.40 in 3Q 2023)

Coral Laboratories Limited to Report Q3, 2024 Results on Feb 14, 2024

Investor sentiment improves as stock rises 17%

Second quarter 2024 earnings released: EPS: ₹16.81 (vs ₹13.70 in 2Q 2023)

New minor risk - Share price stability

Investor sentiment improves as stock rises 26%

Coral Laboratories Limited to Report Q2, 2024 Results on Nov 09, 2023

Coral Laboratories Limited to Report Q1, 2024 Results on Aug 12, 2023

Full year 2023 earnings released: EPS: ₹18.04 (vs ₹25.32 in FY 2022)

Coral Laboratories Limited, Annual General Meeting, Aug 11, 2023

New major risk - Market cap size

Full year 2023 earnings released: EPS: ₹18.04 (vs ₹25.32 in FY 2022)

Coral Laboratories Limited to Report Q4, 2023 Results on May 23, 2023

Third quarter 2023 earnings released: EPS: ₹2.40 (vs ₹0.69 in 3Q 2022)

Coral Laboratories Limited to Report Q3, 2023 Results on Feb 14, 2023

Second quarter 2023 earnings released: EPS: ₹13.70 (vs ₹1.26 in 2Q 2022)

Second quarter 2023 earnings released: EPS: ₹13.70 (vs ₹1.26 in 2Q 2022)

Coral Laboratories Limited to Report Q2, 2023 Results on Nov 11, 2022

First quarter 2023 earnings released: EPS: ₹4.44 (vs ₹16.24 in 1Q 2022)

Coral Laboratories Limited, Annual General Meeting, Sep 29, 2022

Full year 2022 earnings released: EPS: ₹25.32 (vs ₹37.94 in FY 2021)

Coral Laboratories Limited to Report Q4, 2022 Results on May 27, 2022

Coral Laboratories Limited Receives Resignation of Sanket Mehta as Independent Director

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Coral Laboratories Limited to Report Q3, 2022 Results on Feb 11, 2022

Investor sentiment deteriorated over the past week

Non-Executive Director Purvi Doshi has left the company

Full year 2021 earnings released: EPS ₹37.94 (vs ₹19.96 in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ₹12.95 (vs ₹6.30 in 3Q 2020)

Investor sentiment improved over the past week

Coral Laboratories Limited to Report Q3, 2021 Results on Feb 11, 2021

New 90-day low: ₹274

New 90-day low: ₹297

New 90-day low: ₹306

Market pulls back on stock over the past week

Coral Laboratories Limited to Report Q2, 2021 Results on Nov 12, 2020

New 90-day high: ₹392

New 90-day high - ₹322

First quarter earnings released

Coral Laboratories Limited to Report Q1, 2021 Results on Sep 04, 2020

Full year earnings released - EPS ₹19.96

New 90-day high - ₹286

New 90-day high - ₹233

CEO報酬分析

CEO（最高経営責任者

在職期間

報酬

取締役

マネジメント基準チェック /34